1525 Superior Avenue, Suite 200
Newport Beach, CA 92663
Phone (949) 650-0506
Fax (949) 999-8126

Receive our newsletter
  Home  
  Our Team  
  Patient Info  
  Contact Us  

News for Healthier Living

Potential Unreliability of ALK Variant Allele Frequency in the Efficacy Prediction of Targeted Therapy in NSCLC

Researchers at the National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing have discovered that the variant allele frequency (VAF) of ALK fusions may not reliably predict the efficacy of targeted therapies in non-small cell lung cancer (NSCLC). This study, published in Frontiers of Medicine, highlights the challenges in using VAF as a biomarker for treatment outcomes in ALK-positive NSCLC patients.

August 27, 2025


August 31 2025

August 30 2025

August 29 2025

August 28 2025

August 27 2025

August 26 2025

August 25 2025

August 24 2025

August 23 2025

August 22 2025

August 21 2025

August 20 2025

August 19 2025

August 18 2025

August 17 2025